HIV-2感染:西欧现行标准治疗与治疗选择综述
本文整合已发表文献与专家经验,为西欧HIV-2感染者提供现行医疗标准建议。内容涵盖诊断、监测和治疗策略,包括一线和二线治疗的有效药物组合、暴露后预防及母婴传播预防,并列出HIV-2耐药相关突变及CCR5/CXCR4核心受体嗜性列表。
要点
- HIV-2在诊断、临床病程及抗逆转录病毒治疗方面与HIV-1存在差异。
- 西欧HIV-2管理经验有限,需依据整合文献与专家经验制定标准。
- 建议涵盖一线/二线药物组合、暴露后预防及母婴传播预防。
核心结论
- 整合文献与专家经验可为西欧HIV-2感染者提供现行医疗标准建议。
研究设计与样本
- 整合已发表的HIV-2文献(流行病学、诊断、临床病程和治疗的研究与报告)及专家诊断与临床照护经验。
主要发现
- HIV-2在诊断程序、临床病程及抗逆转录病毒治疗方面与HIV-1存在差异特征。
关键数值与推荐
- 提供一线和二线治疗有效药物组合的建议。
- 提供暴露后预防及预防母婴传播的建议。
- 列出HIV-2耐药相关突变及CCR5和CXCR4核心受体嗜性列表。
临床怎么用
- 为西欧国家HIV-2感染者的诊断、监测和治疗提供参考策略。
局限性
- 欧洲HIV-2患病率较低,管理经验和知识有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human immunodeficiency virus-2 (HIV-2) is endemic in some countries in West Africa. Due to the lower prevalence in industrialized countries, there is limited experience and knowledge on the management of individuals living with HIV-2 in Europe. Compared to HIV-1, there are differential characteristics of HIV-2 regarding diagnostic procedures, the clinical course, and, most importantly, antiretroviral therapy. We integrated the published literature on HIV-2 (studies and reports on epidemiology, diagnostics, the clinical course, and treatment), as well as expert experience in diagnosing and clinical care, to provide recommendations for a present standard of medical care of those living with HIV-2 in Western European countries, including an overview of strategies for diagnosis, monitoring, and treatment, with suggestions for effective drug combinations for first- and second-line treatments, post-exposure prophylaxis, and the prevention of mother-to-child transmission, as well as listings of mutations related to HIV-2 drug resistance and C-C motif chemokine receptor type 5 and C-X-C motif chemokine receptor type 4 coreceptor tropism.
引用
- Berzow D, Descamps D, Obermeier M, et al. Human Immunodeficiency Virus-2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe. Clin Infect Dis. 2021. PMID: 32227124. doi:10.1093/cid/ciaa275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。